Country for PR: China
Contributor: PR Newswire Asia (China)
Friday, October 22 2021 - 21:45
AsiaNet
Red Ginseng's possible Vaccine Adjuvant Effect gave out from Korean Ginseng Research Institute
SEOUL, South Korea, Oct. 22, 2021 /PRNewswire-AsiaNet/ --

-We are advised by the client that there are several changes in the release 
content. The complete, corrected version of the news release issued on 
21-Oct-2021 by Korean Ginseng Research Institute over PR Newswire is as follows:

Korean Ginseng Research Institute, recently published research results on 'the 
vaccine adjuvant effect of red ginseng' and 'respiratory damage prevention 
effect'. It is said that red ginseng acts as a potential vaccine adjuvant [1] 
by enhancing the efficacy of the vaccine.

The results of the study showed that red ginseng increased the effectiveness of 
the vaccine, so that when red ginseng was taken together, the antiviral effect 
was enhanced and prevented lung damage caused by various viruses compared to 
when the vaccine was administered alone. The study results that ingestion of 
red ginseng at the same time as the vaccination at the time the inoculation of 
the corona virus vaccine started can increase the vaccine effect is significant 
in that it suggests the possibility of speeding up the overcoming of the 
COVID-19.

In the paper 'Protective Effect of Korean Red Ginseng Extract on the Infections 
by H1N1 and H3N2 Influenza Viruses in Mice' published in 2021 in the 'Journal 
of Medicinal Food', an international academic journal, it was confirmed that 
the survival rate of mice vaccinated with red ginseng concentrate was higher 
than that of mice vaccinated alone. After administering the red ginseng 
concentrate to mice for 14 days, the vaccine was inoculated, and after the last 
administration of the red ginseng concentrate, the mice got infected with 
influenza virus (H1N1, H3N2) and observed. As a result, it was found that when 
the red ginseng concentrate was administered, the virus defense effect was 
strengthened and the production of viral inflammatory substances in the lungs 
was reduced.

In the paper 'Korean Red Ginseng enhances pneumococcal A pep27 vaccine efficacy 
by inhibiting reactive oxygen species production' published in 'Journal of 
Ginseng Research' in 2019, red ginseng concentrate was administered to mice. 
After administration of the vaccine (A pep27) and infection with pneumococcus, 
it was observed that the red ginseng concentrate increased the antibody 
formation and survival rate of mice infected with pneumococcus, and reduced the 
time required for immunization by enhancing the efficacy of the vaccine.

The Institute said that these research results proved the vaccine adjuvant 
effect and respiratory damage prevention effect of red ginseng, and plans to 
continue researching on various viruses through clinical trials.

[1]. Scientific reference about COVID-19 vaccine adjuvant effect of Ginseng: 
https://www.sciencedirect.com/science/article/pii/S1226845320301883 

SOURCE: Korean Ginseng Research Institute

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=404950

   Caption: Red Ginseng

Attachments
1.jpg
Translations

Japanese